Insider Transactions in Q2 2024 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 11
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-0.11%
|
$0
$0.61 P/Share
|
Jun 04
2024
|
John Markels |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.94%
|
-
|
Jun 04
2024
|
James R Meyers |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.1%
|
-
|
Jun 04
2024
|
H Stewart Parker |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+22.2%
|
-
|
Jun 04
2024
|
Karen L. Smith |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+24.49%
|
-
|
Jun 04
2024
|
Courtney Beers |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+30.25%
|
-
|
Jun 04
2024
|
Robert Carey |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.1%
|
-
|
Jun 04
2024
|
Kenneth J. Hillan |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.1%
|
-
|
Jun 04
2024
|
Margaret A Horn |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+30.25%
|
-
|
May 25
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,336
-0.16%
|
$0
$0.6 P/Share
|
May 25
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,508
-0.18%
|
$0
$0.6 P/Share
|
May 25
2024
|
Amy Pooler VP, HEAD OF RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
493
-0.25%
|
$0
$0.6 P/Share
|
May 25
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-0.16%
|
$0
$0.6 P/Share
|
May 25
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
7,492
-0.29%
|
$0
$0.6 P/Share
|
May 24
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,400
-0.17%
|
$0
$0.6 P/Share
|
May 24
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-0.21%
|
$0
$0.6 P/Share
|
May 24
2024
|
Amy Pooler VP, HEAD OF RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-0.36%
|
$0
$0.6 P/Share
|
May 24
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-0.21%
|
$0
$0.6 P/Share
|
May 24
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
5,261
-0.21%
|
$0
$0.6 P/Share
|